Future_Medicinal_Chemistry

<i>Future Medicinal Chemistry</i>

Future Medicinal Chemistry

Academic journal

Future Medicinal Chemistry is a peer-reviewed medical journal covering all aspects of medicinal chemistry, including drug discovery, pharmacology, in silico drug design, structural characterization techniques, ADME-Tox investigations, and science policy, economic and intellectual property issues. It was established in 2009 and is published by Future Science. The editors-in-chief are Iwao Ojima (The State University of New York at Stony Brook) and Jonathan Baell (Monash University).

Quick Facts Discipline, Language ...

Abstracting and indexing

The journal is abstracted and indexed by BIOSIS Previews, Chemical Abstracts, Chemistry Citation Index, Embase/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2020 impact factor of 3.808.[1]

References

  1. [1]
    "Future Medicinal Chemistry". 2020 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021.


Stub icon 1 Stub icon 2

This article about a medicinal chemistry journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
Share this article:

This article uses material from the Wikipedia article Future_Medicinal_Chemistry, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.